Literature DB >> 32418477

Phosphodiesterase 9 Inhibition in Models of Heart Failure With Preserved Left Ventricular Ejection Fraction: Should We Focus on the Positive or Negative?

Robert M Blanton1.   

Abstract

Entities:  

Keywords:  Editorials; heart failure; humans; hypertrophy; insulin resistance

Mesh：

Substances：

Year:  2020        PMID： 32418477      PMCID： PMC7425775          DOI： 10.1161/CIRCHEARTFAILURE.120.007107

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  12 in total

1.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

Review 2.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

3.  Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.

Authors:  Michael R Zile; Catalin F Baicu; John S Ikonomidis; Robert E Stroud; Paul J Nietert; Amy D Bradshaw; Rebecca Slater; Bradley M Palmer; Peter Van Buren; Markus Meyer; Margaret M Redfield; David A Bull; Henk L Granzier; Martin M LeWinter
Journal:  Circulation       Date:  2015-01-30       Impact factor: 29.690

4.  C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.

Authors:  Pan-Xia Wang; Zhuo-Ming Li; Si-Dong Cai; Jing-Yan Li; Ping He; Yi Huang; Guo-Shuai Feng; Hai-Bin Luo; Shao-Rui Chen; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

5.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

6.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Authors:  Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

7.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

8.  Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Paul W Armstrong; Burkert Pieske; Kevin J Anstrom; Justin Ezekowitz; Adrian F Hernandez; Javed Butler; Carolyn S P Lam; Piotr Ponikowski; Adriaan A Voors; Gang Jia; Steven E McNulty; Mahesh J Patel; Lothar Roessig; Joerg Koglin; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2020-03-28       Impact factor: 91.245

9.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

Authors:  Margaret M Redfield; Kevin J Anstrom; James A Levine; Gabe A Koepp; Barry A Borlaug; Horng H Chen; Martin M LeWinter; Susan M Joseph; Sanjiv J Shah; Marc J Semigran; G Michael Felker; Robert T Cole; Gordon R Reeves; Ryan J Tedford; W H Wilson Tang; Steven E McNulty; Eric J Velazquez; Monica R Shah; Eugene Braunwald
Journal:  N Engl J Med       Date:  2015-11-08       Impact factor: 91.245

10.  Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.

Authors:  Mei Methawasin; Joshua Strom; Tomasz Borkowski; Zaynab Hourani; Ray Runyan; John E Smith; Henk Granzier
Journal:  Circ Heart Fail       Date:  2020-05-18       Impact factor: 8.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.